PECAM1 and lung cancer: This evidence supports our findings and strongly suggests that a high intake of ω-6 PUFAs leads to a more aggressive phenotype of lung cancer mediated through pro-tumor oxylipins and high expression of VEGF-A, CD31, YY1, COX-2 and TGF-β.